Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function

References

• RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
   PubMed Web of Science ®Google Scholar
• LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
   PubMed Web of Science ®Google Scholar
• HongYLeeJSYooKHImplications of emphysema and lung function for the development of pneumonia in patients with chronic obstructive pulmonary diseaseTuberc Respir Dis (Seoul)2016792919727066086
   PubMedGoogle Scholar
• PettyTLScope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and interventionChest20001175 Suppl 2326S331S10843971
   PubMed Web of Science ®Google Scholar
• PauwelsRCOPD: the scope of the problem in EuropeChest20001175 Suppl 2332S335S10843972
   PubMed Web of Science ®Google Scholar
• HurdSThe impact of COPD on lung health worldwide: epidemiology and incidenceChest20001172 Suppl1S4S10673465
   PubMed Web of Science ®Google Scholar
• MenezesAMPerez-PadillaRJardimJRPLATINO TeamChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
   PubMed Web of Science ®Google Scholar
• BuistASMcBurnieMAVollmerWMBOLD Collaborative Research GroupInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
   PubMed Web of Science ®Google Scholar
• KimDSKimYSJungKSKorean Academy of Tuberculosis and Respiratory DiseasesPrevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry surveyAm J Respir Crit Care Med2005172784284715976382
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBRDecramerMLystigTLiuDKestenSEfficacy of tiotropium in COPD patients with FEV1 ≥60% participating in the UPLIFT® trialCOPD20129328929622432932
   PubMedGoogle Scholar
• YooKHKimYSSheenSSPrevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008Respirology201116465966521342331
   PubMed Web of Science ®Google Scholar
• LeeJYRheeCKJungKSYooKHStrategies for management of the early chronic obstructive lung diseaseTuberc Respir Dis (Seoul)201679312112627433171
   PubMedGoogle Scholar
• ShinCLeeSAbbottRDRespiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: the Korean Health and Genome StudyChest200412641234124015486387
   PubMed Web of Science ®Google Scholar
• BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax200863540240718234906
   PubMed Web of Science ®Google Scholar
• LeeJYChonGRRheeCKCharacteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COPD Subgroup Study Team CohortJ Korean Med Sci201631455356027051239
   PubMed Web of Science ®Google Scholar
• EuroQol GroupEuroQol – a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
   PubMed Web of Science ®Google Scholar
• MeguroMBarleyEASpencerSJonesPWDevelopment and validation of an improved, COPD-specific version of the St George Respiratory QuestionnaireChest2007132245646317646240
   PubMed Web of Science ®Google Scholar
• JonesPWFordeYSt George’s Respiratory Questionnaire for COPD Patients (SGRQ-C) ManualLondonSt George’s University of London2008
   Google Scholar
• TsiligianniIGvan der MolenTMoraitakiDAssessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)BMC Pulm Med2012122022607459
   PubMed Web of Science ®Google Scholar
• KimCYooKHRheeCKHealth care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in KoreaInt J Tuberc Lung Dis201418673774324903947
   PubMed Web of Science ®Google Scholar
• RheeCKYoonHKYooKHMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthmaCOPD201411216317024111662
   PubMedGoogle Scholar
• KimJKimKKimYThe association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patientsRespir Med2014108115316123993445
   PubMed Web of Science ®Google Scholar
• KimJRheeCKYooKHThe health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service dataInt J Chron Obstruct Pulmon Dis2013856156824277985
   PubMed Web of Science ®Google Scholar
• HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
   PubMed Web of Science ®Google Scholar
• GeijerRMSachsAPVerheijTJSaloméPLLammersJWHoesAWIncidence and determinants of moderate COPD (GOLD II) in male smokers aged 40–65 years: 5-year follow upBr J Gen Pract20065653065666116953996
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• ManninoDMSonia BuistAVollmerWMChronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?Thorax200762323724117090573
   PubMed Web of Science ®Google Scholar
• ManninoDMBuistASPettyTLEnrightPLReddSCLung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyThorax200358538839312728157
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med2008178433233818511702
   PubMed Web of Science ®Google Scholar